Research

SIMRIS ALG: Ready to execute on a three-pronged roadmap to capture the most high-value opportunities

2022-11-11• Analys, Research

Following the successful acquisition of Cyano Biotech GmbH in Q3, Simris is now moving forward with a three-pronged approach to value...

Read More →

DLABORATORY: Strong growth and positive EBITDA a welcome shift in pace

2022-11-04• Analys, Research

With a steep increase in revenue, 35% recurring revenue growth, turn to positive EBITDA of SEK 2.2m and a forward-leaning statement from...

Read More →

NANEXA: Charging to enter triple clinical trials in the coming year

2022-10-26• Analys, Research

Besides starting its third proprietary development project in Q2 (NEX-22, a long-acting formulation of liraglutide for treatment of type 2...

Read More →

KEBNI: Saab order the portal to next level for KebNi

2022-10-17• Analys, Research

With the SEK 76m volume order for IMUs from Saab, KebNi now enters the next level of monetising its IMU technology. The order however only...

Read More →

AGTIRA: Snowballing with Farming as a Service

2022-10-14• Analys, Research

It took less than five months for Agtira to convert the LOI with Greenfood into a firm order of SEK 80m, the first of potentially ten, and...

Read More →

SWEDISH STIRLING: Revising near-term fundamentals after aborted preference share issue

2022-09-29• Analys, Research

With the planned preference share issue cancelled with reference to market conditions, Swedish Stirling is now returning to its original...

Read More →

MELTRON: Bright outlook with triggers ahead

2022-09-29• Analys, Research

With a difficult fiscal year now in the books, Meltron is looking to start over with an increased focus on cost efficiency, direct sales...

Read More →

GRANGEX: Upwards revision of reserves accompanied by strong macro backdrop

2022-09-21• Analys, Research

GRÄNGESBERG EXPLORATION The ongoing preparations for the DFS of Dannemora has now yielded its second upwards revision, a 16% increase in...

Read More →

MOTION DISPLAY: Important pieces in place for stronger H2’22 and international expansion beyond

2022-09-16• Analys, Research

With a unique technique and great cost advantages, Motion Display’s e-paper displays are well documented to produce a dramatic increase...

Read More →

NANEXA: New project NEX-22 to add significant daily benefits for 50m patient market

2022-09-16• Analys, Research

Nanexa’s next proprietary development project, NEX-22, is a long-acting formulation of liraglutide for treatment of type 2 diabetes...

Read More →

SIMRIS ALG: Ready to execute on a three-pronged roadmap to capture the most high-value opportunities

DLABORATORY: Strong growth and positive EBITDA a welcome shift in pace

NANEXA: Charging to enter triple clinical trials in the coming year

KEBNI: Saab order the portal to next level for KebNi

AGTIRA: Snowballing with Farming as a Service

SWEDISH STIRLING: Revising near-term fundamentals after aborted preference share issue

MELTRON: Bright outlook with triggers ahead

GRANGEX: Upwards revision of reserves accompanied by strong macro backdrop

MOTION DISPLAY: Important pieces in place for stronger H2’22 and international expansion beyond

NANEXA: New project NEX-22 to add significant daily benefits for 50m patient market

Widmark Research

CONTACT